AngioDynamics (ANGO) News Today → [PDF Inside] Crypto's $1 Trillion 60-Day Boom + New 2024 Profit Strategy (From DeFi Distribution) (Ad) Free ANGO Stock Alerts $6.45 +0.20 (+3.20%) (As of 02:57 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 6, 2024 | marketbeat.comArmistice Capital LLC Invests $6.27 Million in AngioDynamics, Inc. (NASDAQ:ANGO)Armistice Capital LLC bought a new position in AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 800,000 shares of the medical instruments supMay 31, 2024 | marketbeat.comAngioDynamics, Inc. (NASDAQ:ANGO) Sees Significant Decrease in Short InterestAngioDynamics, Inc. (NASDAQ:ANGO - Get Free Report) saw a large decrease in short interest during the month of May. As of May 15th, there was short interest totalling 1,790,000 shares, a decrease of 16.7% from the April 30th total of 2,150,000 shares. Based on an average daily volume of 517,200 shares, the days-to-cover ratio is currently 3.5 days.May 31, 2024 | americanbankingnews.comQ2 2025 EPS Estimates for AngioDynamics, Inc. (NASDAQ:ANGO) Decreased by Zacks ResearchMay 30, 2024 | marketbeat.comAnalysts Set Expectations for AngioDynamics, Inc.'s Q2 2025 Earnings (NASDAQ:ANGO)AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) - Zacks Research lowered their Q2 2025 earnings per share estimates for AngioDynamics in a research report issued on Monday, May 27th. Zacks Research analyst D. Dey now forecasts that the medical instruments supplier will post earnings of ($0.15) peMay 29, 2024 | bizjournals.comAngioDynamics CEO on what's next after outsourcing moveMay 24, 2024 | marketbeat.comQ4 2024 EPS Estimates for AngioDynamics, Inc. (NASDAQ:ANGO) Decreased by AnalystAngioDynamics, Inc. (NASDAQ:ANGO - Free Report) - Research analysts at HC Wainwright decreased their Q4 2024 EPS estimates for AngioDynamics in a research note issued on Wednesday, May 22nd. HC Wainwright analyst Y. Chen now anticipates that the medical instruments supplier will post earnings perMay 22, 2024 | markets.businessinsider.comBuy Rating on AngioDynamics: Growth and Regulatory Approvals Underscore Positive OutlookMay 22, 2024 | finance.yahoo.comInvestors in AngioDynamics (NASDAQ:ANGO) have unfortunately lost 75% over the last three yearsMay 22, 2024 | marketbeat.comAngioDynamics (NASDAQ:ANGO) Given "Buy" Rating at HC WainwrightHC Wainwright reaffirmed a "buy" rating and issued a $14.00 target price on shares of AngioDynamics in a report on Wednesday.May 22, 2024 | markets.businessinsider.comANGO : AlphaVac F1885 Secures CE Mark For Non-Surgical Pulmonary Embolism Treatment In EuropeMay 21, 2024 | businesswire.comAngioDynamics Announces CE Mark Approval in Europe for AlphaVac F18⁸⁵ SystemMay 6, 2024 | finance.yahoo.comAngioDynamics’ APEX-AV Trial Results Assessing AlphaVac F18⁸⁵ System in Treatment of Pulmonary Embolism Presented at SCAI 2024 Scientific SessionsMay 6, 2024 | businesswire.comAngioDynamics' APEX-AV Trial Results Assessing AlphaVac F18⁸⁵ System in Treatment of Pulmonary Embolism Presented at SCAI 2024 Scientific SessionsMay 3, 2024 | nasdaq.comAngioDynamics, Inc. Common Stock (ANGO)May 2, 2024 | finance.yahoo.comOppenheimer Predicts Over 100% Rally for These 2 Healthcare StocksApril 17, 2024 | finance.yahoo.comAngioDynamics, Inc. (ANGO) Interactive Stock Chart - Yahoo FinanceApril 15, 2024 | marketbeat.comAngioDynamics, Inc. (NASDAQ:ANGO) Sees Large Decline in Short InterestAngioDynamics, Inc. (NASDAQ:ANGO - Get Free Report) was the target of a significant drop in short interest during the month of March. As of March 31st, there was short interest totalling 2,250,000 shares, a drop of 8.5% from the March 15th total of 2,460,000 shares. Based on an average daily volume of 575,400 shares, the short-interest ratio is currently 3.9 days.April 10, 2024 | finance.yahoo.comInsider Spends US$67k Buying More Shares In AngioDynamicsApril 9, 2024 | seekingalpha.comA Leaner AngioDynamics Is A High-Risk Execution-Driven StoryApril 9, 2024 | insidertrades.comJames C. Clemmer Acquires 10,000 Shares of AngioDynamics, Inc. (NASDAQ:ANGO) StockApril 8, 2024 | marketbeat.comInsider Buying: AngioDynamics, Inc. (NASDAQ:ANGO) CEO Purchases 10,000 Shares of StockAngioDynamics, Inc. (NASDAQ:ANGO - Get Free Report) CEO James C. Clemmer acquired 10,000 shares of AngioDynamics stock in a transaction dated Monday, April 8th. The shares were acquired at an average price of $6.70 per share, with a total value of $67,000.00. Following the completion of the acquisition, the chief executive officer now directly owns 539,066 shares of the company's stock, valued at $3,611,742.20. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.April 8, 2024 | finance.yahoo.comAngioDynamics, Inc. (NASDAQ:ANGO) Q3 2024 Earnings Call TranscriptApril 6, 2024 | finance.yahoo.comAngioDynamics Third Quarter 2024 Earnings: Misses ExpectationsApril 6, 2024 | seekingalpha.comAngioDynamics (ANGO) Q3 2024 Earnings Call TranscriptApril 6, 2024 | markets.businessinsider.comBuy Rating Affirmed for AngioDynamics Amid Strong Sales and Strategic Growth OpportunitiesApril 6, 2024 | markets.businessinsider.comBuy Rating Reaffirmed for AngioDynamics Amidst Strategic Growth and Med-Tech Sector PotentialApril 5, 2024 | msn.comAngioDynamics upgraded at Oppenheimer on pipeline progressApril 4, 2024 | finance.yahoo.comMedical Devices Focused AngioDynamics Unveils Upbeat 2024 Financial Outlook, Stock SoarsApril 4, 2024 | marketwatch.comAngioDynamics Shares Rise 10% After FDA Clears AlphaVac F18 SystemApril 4, 2024 | markets.businessinsider.comANGO Stock Earnings: AngioDynamics Misses EPS, Misses Revenue for Q3 2024April 4, 2024 | marketbeat.comAngioDynamics (NASDAQ:ANGO) Releases FY 2024 Earnings GuidanceAngioDynamics (NASDAQ:ANGO) updated its FY 2024 earnings guidance. The company provided EPS guidance of -0.580--0.540 for the period, compared to the consensus estimate of -0.430. The company also issued revenue guidance of $270.0 millionillion-$275.0 millionillion, compared to the consensus estimate of $312.1 millionillion.April 4, 2024 | marketwatch.comAngioDynamics Gets FDA Clearance For Pulmonary Embolism TreatmentApril 4, 2024 | marketwatch.comAngioDynamics Cut Fiscal-Year Revenue Outlook, Reflecting DivestmentsApril 4, 2024 | sfgate.comAngioDynamics: Fiscal Q3 Earnings SnapshotApril 4, 2024 | markets.businessinsider.comAngioDynamics: FDA Clears AlphaVac F1885 System In Treatment Of Pulmonary EmbolismApril 4, 2024 | markets.businessinsider.comAngioDynamics Q3 Loss Sharply Widens; Slashes FY24 OutlookApril 4, 2024 | msn.comAngioDynamics gets FDA clearance for pulmonary embolism treatment deviceApril 4, 2024 | businesswire.comAngioDynamics Reports Fiscal Year 2024 Third Quarter Financial Results; Updates Fiscal Year 2024 Guidance to Reflect Asset DivestitureApril 4, 2024 | businesswire.comAngioDynamics Receives 510(k) Clearance for AlphaVac F1885 System in Treatment of PEApril 2, 2024 | msn.comAngioDynamics Resolves Decade-Long Patent Litigation With Becton, Dickinson In Settlement AgreementApril 2, 2024 | markets.businessinsider.comAngioDynamics Settles All Patent Litigation With C.R. BardApril 1, 2024 | marketwatch.comAngioDynamics Settles Multi-Year Patent Dispute with Becton Dickinson & CoApril 1, 2024 | businesswire.comAngioDynamics Announces Settlement of All Patent Litigation with C.R. Bard, Inc.March 19, 2024 | businesswire.comAngioDynamics to Report Fiscal 2024 Third Quarter Financial Results on April 4, 2024March 18, 2024 | marketbeat.comQ3 2024 EPS Estimates for AngioDynamics, Inc. Reduced by Zacks Research (NASDAQ:ANGO)AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) - Zacks Research lowered their Q3 2024 earnings per share (EPS) estimates for AngioDynamics in a research report issued on Wednesday, March 13th. Zacks Research analyst D. Dey now expects that the medical instruments supplier will earn ($0.15) per sMarch 18, 2024 | marketbeat.comShort Interest in AngioDynamics, Inc. (NASDAQ:ANGO) Rises By 8.5%AngioDynamics, Inc. (NASDAQ:ANGO - Get Free Report) was the recipient of a significant growth in short interest in the month of February. As of February 29th, there was short interest totalling 2,300,000 shares, a growth of 8.5% from the February 14th total of 2,120,000 shares. Based on an average daily trading volume, of 522,400 shares, the days-to-cover ratio is presently 4.4 days.March 15, 2024 | marketbeat.comQ3 2026 EPS Estimates for AngioDynamics, Inc. Lowered by Zacks Research (NASDAQ:ANGO)AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) - Equities researchers at Zacks Research cut their Q3 2026 earnings estimates for AngioDynamics in a research note issued to investors on Wednesday, March 13th. Zacks Research analyst D. Dey now expects that the medical instruments supplier will posMarch 14, 2024 | marketbeat.comJacobs Levy Equity Management Inc. Grows Stock Holdings in AngioDynamics, Inc. (NASDAQ:ANGO)Jacobs Levy Equity Management Inc. grew its holdings in AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 62.4% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 713,899 shares of the medical instruments supplieMarch 6, 2024 | businesswire.comAngioDynamics to Participate in a Fireside Chat at the Oppenheimer Virtual Healthcare MedTech & Services ConferenceMarch 5, 2024 | marketbeat.comTrexquant Investment LP Makes New Investment in AngioDynamics, Inc. (NASDAQ:ANGO)Trexquant Investment LP purchased a new stake in AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 187,854 shares of the medical instruments supplier's stock, v Get AngioDynamics News Delivered to You Automatically Sign up to receive the latest news and ratings for ANGO and its competitors with MarketBeat's FREE daily newsletter. Email Address [PDF Inside] Crypto's $1 Trillion 60-Day Boom + New 2024 Profit Strategy (Ad)The crypto industry is exploding and Chris Munch just released a new PDF detailing how you can potentially profit from this trillion-dollar niche WITHOUT buying a single coin, NFT or investing in ANYTHING. Grab the PDF here for free: ANGO Media Mentions By Week ANGO Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ANGO News Sentiment▼1.540.76▲Average Medical News Sentiment ANGO News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ANGO Articles This Week▼13▲ANGO Articles Average Week Get AngioDynamics News Delivered to You Automatically Sign up to receive the latest news and ratings for ANGO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Cytosorbents News Today Surmodics News Today Orthofix Medical News Today Accuray News Today Rockwell Medical News Today ReShape Lifesciences News Today Abbott Laboratories News Today Intuitive Surgical News Today Stryker News Today Boston Scientific News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ANGO) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | Sponsored[PDF Inside] Crypto's $1 Trillion 60-Day Boom + New 2024 Profit StrategyThe crypto industry is exploding and Chris Munch just released a new PDF detailing how you can potentially pro...DeFi Distribution | SponsoredIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...Smallcaps Daily | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredMoonshot Coins for the Current Crypto RunDid you see bitcoin crossed $70k again? Don't miss the next bull run. Because while Bitcoin and Ethereum s...Crypto 101 Media | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | Sponsored